ABT1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.548410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.205800E-01
Normal-vs-Stage2
1.535990E-01
Normal-vs-Stage3
2.601000E-01
Normal-vs-Stage4
9.154200E-01
Stage1-vs-Stage2
7.169400E-01
Stage1-vs-Stage3
2.853400E-01
Stage1-vs-Stage4
2.740200E-01
Stage2-vs-Stage3
2.828400E-01
Stage2-vs-Stage4
1.445830E-01
Stage3-vs-Stage4
1.156020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.691360E-01
Normal-vs-AfricanAmerican
3.806200E-01
Normal-vs-Asian
3.066000E-01
Caucasian-vs-AfricanAmerican
7.859800E-01
Caucasian-vs-Asian
8.114800E-01
AfricanAmerican-vs-Asian
9.261000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.494980E-01
Normal-vs-Female
1.917240E-01
Male-vs-Female
2.873000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.910000E-01
Normal-vs-Age(41-60Yrs)
5.067000E-01
Normal-vs-Age(61-80Yrs)
1.706760E-01
Normal-vs-Age(81-100Yrs)
7.998800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.546610E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.487200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.899800E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.939800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.834360E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.768400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.122800E-01
Normal-vs-Daily Drinker
1.882240E-01
Normal-vs-Weekly Drinker
2.754800E-01
Normal-vs-Occasional Drinker
2.758600E-01
Normal-vs-Social Drinker
3.972400E-01
Non Drinker-vs-Daily Drinker
9.453000E-01
Non Drinker-vs-Weekly Drinker
6.737200E-01
Non Drinker-vs-Occasional Drinker
4.478200E-01
Non Drinker-vs-Social Drinker
4.943400E-01
Daily Drinker-vs-Weekly Drinker
6.232200E-01
Daily Drinker-vs-Occasional Drinker
4.003600E-01
Daily Drinker-vs-Social Drinker
5.640400E-01
Weekly Drinker-vs-Occasional Drinker
7.758800E-01
Weekly Drinker-vs-Social Drinker
2.570600E-01
Occasional Drinker-vs-Social Drinker
1.114980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.244020E-01
Normal-vs-Grade 2
5.598100E-02
Normal-vs-Grade 3
8.680000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.759400E-01
Grade 1-vs-Grade 3
9.114400E-01
Grade 1-vs-Grade 4
1.244020E-01
Grade 2-vs-Grade 3
6.073000E-01
Grade 2-vs-Grade 4
5.598100E-02
Grade 3-vs-Grade 4
8.680000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.816200E-01
Normal-vs-NonDiabetic
4.693800E-01
Diabetic-vs-NonDiabetic
4.010600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.520800E-01
Normal-vs-NoPancreatitis
1.854360E-01
Pancreatitis-vs-NoPancreatitis
3.465500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.865160E-01
Normal-vs-N1
1.708200E-01
N0-vs-N1
6.776600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.318800E-01
Normal-vs-TP53-NonMutant
4.268200E-01
TP53-Mutant-vs-TP53-NonMutant
4.372000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
